Laura Gaylen Goldsmith

Laura Goldsmith practices at Saint John's Physician Partners in Santa Monica, California.

Laura Goldsmith's NPI, 1629624077, was assigned on August 12, 2019. Laura Goldsmith holds California license 95012241.

Laura Goldsmith's primary practice is Saint John's Physician Partners, at 901 Wilshire Blvd, Santa Monica, CA 90401 in Los Angeles County. The practice phone is (310) 582-7312.

Laura Goldsmith's primary practice is Saint John's Physician Partners in Santa Monica, California. Laura Goldsmith is also affiliated with Providence Saint John's Health Center. The medical group on file is Saint John's Physician Partners. Dmand AI also links Laura Goldsmith to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Laura Goldsmith practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Laura Goldsmith's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Laura Goldsmith is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, chest wall injury, chronic diabetes, chronic kidney disease, cold sores or genital herpes, diabetic emergency and ear infection among the conditions Laura Goldsmith treats.

CMS data shows 486 Medicare services from Laura Goldsmith across 14 procedure codes in 2024, for 274 Medicare patients. Medicare paid $22,474 for them.

CMS counts 274 Medicare patients who saw Laura Goldsmith in 2024. The largest group is 65 to 74, with 133 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Laura Goldsmith's median patient age at 59, with 66% women.

In 2024, Laura Goldsmith wrote 348 Medicare Part D claims for 209 patients. 91% of them were for generic drugs. CMS names the drug for 91 of them, across 5 drugs with 11 or more claims each, at $528 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Laura Goldsmith for performance year 2024, reported as part of a group. Laura Goldsmith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Laura Goldsmith as offering telehealth.

CMS Open Payments shows 7 general payments to Laura Goldsmith from 6 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Eli Lilly and Company paid the most, $49.